506 related articles for article (PubMed ID: 19931264)
21. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
[TBL] [Abstract][Full Text] [Related]
22. Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure.
Fenton H; Torbenson M; Vivekanandan P; Yeh MM; Hart J; Ferrell L
Transplantation; 2009 Apr; 87(8):1256-60. PubMed ID: 19384175
[TBL] [Abstract][Full Text] [Related]
23. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
24. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?
Bhattacharya R; Kowdley KV
Gastroenterology; 2003 Aug; 125(2):615-6; discussion 617. PubMed ID: 12891567
[No Abstract] [Full Text] [Related]
25. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
26. Hepatic iron loading in patients with compound heterozygous HFE mutations.
Lim EM; Rossi E; De Boer WB; Reed WD; Jeffrey GP
Liver Int; 2004 Dec; 24(6):631-6. PubMed ID: 15566515
[TBL] [Abstract][Full Text] [Related]
27. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
Nelson JE; Bhattacharya R; Lindor KD; Chalasani N; Raaka S; Heathcote EJ; Miskovsky E; Shaffer E; Rulyak SJ; Kowdley KV
Hepatology; 2007 Sep; 46(3):723-9. PubMed ID: 17680648
[TBL] [Abstract][Full Text] [Related]
28. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
30. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
Chan AT; Ma J; Tranah GJ; Giovannucci EL; Rifai N; Hunter DJ; Fuchs CS
J Natl Cancer Inst; 2005 Jun; 97(12):917-26. PubMed ID: 15956653
[TBL] [Abstract][Full Text] [Related]
31. The influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
[TBL] [Abstract][Full Text] [Related]
32. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
[TBL] [Abstract][Full Text] [Related]
33. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A
Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835
[TBL] [Abstract][Full Text] [Related]
34. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations.
Neri S; Pulvirenti D; Signorelli S; Ignaccolo L; Tsami A; Mauceri B; Misseri M; Interlandi D; Cutuli N; Castellino P
Intern Med J; 2008 Apr; 38(4):254-8. PubMed ID: 17916170
[TBL] [Abstract][Full Text] [Related]
35. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.
Valenti L; Dongiovanni P; Fracanzani AL; Santorelli G; Fatta E; Bertelli C; Taioli E; Fiorelli G; Fargion S
Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071
[TBL] [Abstract][Full Text] [Related]
36. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
37. Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy.
Hannuksela J; Leppilampi M; Peuhkurinen K; Kärkkäinen S; Saastamoinen E; Heliö T; Kaartinen M; Nieminen MS; Nieminen P; Parkkila S
Eur J Heart Fail; 2005 Jan; 7(1):103-8. PubMed ID: 15642540
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
[TBL] [Abstract][Full Text] [Related]
39. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
40. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Lonjon I; Bastie A; Duvoux C; Pawlotsky JM; Zafrani ES; Amselem S; Dhumeaux D
J Hepatol; 1999 Dec; 31(6):979-84. PubMed ID: 10604569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
